UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of ~~the~~ ~~Securities Exchange Act of 1934~~

~~Date of~~the ~~Report~~Securities ~~(Date~~Exchange Act of ~~earliest event reported): December 13, 2010~~1934

Date of Report (Date of earliest event reported): February 19, 2011

iTech Medical, Inc.

(Exact name of registrant as specified in its charter)

Delaware	000-52117	20-5153331
(State of other jurisdiction	(Commission File Number)	(IRS Employer
of incorporation)		Identification No.)
	17011 Beach Boulevard, Suite 900 Huntington Beach, California 92647
	17011 Beach Boulevard Suite 900 Huntington Beach, California 92647
	(Address of principal executive offices)

(714) 841-2670

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8 5.~~01 Other~~02 ~~Events~~Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

~~On December~~Election ~~13,~~of 2010, the Company issued a press release announcing that it had received a license from Health Canada approving the Company’s Muscle Pattern Recognition (MPR) System for sale in Canada. The Press Release is filed as Exhibit 99.1 to this Form 8-K.Director

On ~~December~~ 15February 19, ~~2010~~2011, the board of directors (the "Board") of iTech Medical, Inc. (the "Company") ~~issued~~elected aWarren ~~press~~G. ~~release~~Baker ~~announcing~~to ~~that~~serve itas ~~had received~~President CEand ~~Mark~~Chief ~~approval~~Operating ~~for~~Officer ~~the~~and ~~commercial~~as ~~sale~~a member of the Company's ~~MPR~~Board. Mr. ~~System~~Baker ~~in Europe. The~~was ~~Press~~appointment ~~Release~~to the Board is ~~filed~~for asa ~~Exhibit~~term ~~99.2~~that toextends ~~this~~until ~~Form 8-K~~the 2011 annual meeting of the shareholders, or until his successor is elected and qualifies.

InFrom ~~accordance~~January ~~with~~2004 ~~General~~until ~~Instruction B~~June 2006, Mr.2 ofBaker ~~Form~~was ~~8-K~~Chief Operating Officer at Advanced Research Technologies (ART) of Montreal, Quebec where he lead the ~~above-referenced~~development ~~Press~~and ~~Release~~commercialization ~~shall~~of ~~not~~their beoptical ~~deemed~~imaging ~~“filed”~~ technology for ~~purposes~~the ofidentification ~~Section~~and 18diagnosis of ~~the~~breast ~~Securities~~cancer ~~Exchange~~and ~~Act~~identification of ~~1934,~~optically astagged ~~amended, or~~biomarkers ~~otherwise~~in ~~subject~~preclinical topharmaceutical ~~the~~studies. From ~~liabilities~~June of2006 ~~that~~until ~~section~~February 2011, ~~nor~~Mr. ~~shall~~Baker ~~the~~was ~~Press Releases~~an beindependent ~~deemed~~healthcare ~~incorporated~~consultant. During bythis ~~reference~~time, inMr. ~~any~~Baker ~~filing~~worked ~~under~~at ~~the~~a ~~Securities Act~~senior ofoperating ~~1933~~level with several medical technology companies including Helius Medical, aseXigen ~~amended~~Medial and iTech Medical. During this time, ~~except~~Mr. asBaker ~~shall~~also beserved ~~expressly~~on ~~set~~the ~~forth~~board byof ~~specific~~directors of ~~reference~~Helius inMedical ~~such~~and aeXigen ~~filing~~Medical.

~~Item~~Mr. 9Baker is 58 years old and there is no family relationship between Mr.~~01.~~ ~~Financial~~Baker ~~Statements~~and any of the Company’s officers and ~~Exhibits~~directors. Mr. Baker’s annual salary will be $120,000.

~~c) Exhibits~~Item 7.01 Regulation FD Disclosure.

Exhibit No.	Description
99.1	Press Release, dated December 13, 2010
99.2	Press Release, dated December 15, 2010

The election of Mr. Baker was announced in the press release attached hereto as Exhibit 99.1 and incorporated by reference herein. The press release is not deemed filed under the Securities Exchange Act of 1933, as amended. It is considered to be “furnished” under the instructions of Form 8-K.

Item 9.01

Financial Statements and Exhibits

99.1	Press Release, dated February 22, 2011, regarding the appointment of Mr. Baker as an officer and a director.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: December 17, 2010	iTech Medical, Inc.
Dated: February 25, 2011	iTech Medical, Inc.
	By:	/s/ Wayne Cockburn
		Wayne Cockburn President and Chief Executive Officer
		Chief Executive Officer

Filing Compare · iTech Medical, Inc.